Corticotropin-releasing factor receptors induce calcium mobilization through cross-talk with Gq-coupled receptors

European Journal of Pharmacology

Volumn 642, Issue 1-3, 2010, Pages 1-9

  Gutknecht, Eric ^a,b   Vauquelin, Georges ^b   Dautzenberg, Frank M ^a,c  

^a JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c Nycomed GmbH   (Germany)

Author keywords

Calcium; Corticotropin releasing factor receptor; Cross talk; Cyclic AMP; G protein coupled receptor; Retinoblastoma

Indexed keywords

CALCIUM; CARBACHOL; CORTICOTROPIN RELEASING FACTOR AGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2A; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; GQ PROTEIN COUPLED RECEPTOR; HORMONE RECEPTOR STIMULATING AGENT; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; MUSCARINIC RECEPTOR; UNCLASSIFIED DRUG; AMPHIBIAN PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR 1; MUSCARINIC AGENT; PEPTIDE HORMONE; SAUVAGINE;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CANCER CELL CULTURE; CELL STIMULATION; CELL STRAIN HEK293; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; RETINOBLASTOMA; SECOND MESSENGER; SIGNAL TRANSDUCTION; STABLE EXPRESSION; AGONISTS; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; TUMOR CELL LINE;

AMPHIBIAN PROTEINS; CALCIUM SIGNALING; CARBACHOL; CELL LINE, TUMOR; CYCLIC AMP; GENE EXPRESSION REGULATION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HUMANS; MUSCARINIC AGONISTS; PEPTIDE HORMONES; RECEPTOR CROSS-TALK; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, MUSCARINIC; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE, TYPE I;

EID: 77954622909     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.05.027     Document Type: Article

References (40)

1. Bak L.K., Schousboe A., Waagepetersen H.S. The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J. Neurochem. 2006, 98:641-653.
2. 2+ signaling in non-excitable cells. Cell Calcium 2003, 34:431-444.
3. Chang C.L., Hsu S.Y. Ancient evolution of stress-regulating peptides in vertebrates. Peptides 2004, 25:1681-1688.
4. Chen C., Dagnino R., De Souza E.B., Grigoriadis D.E., Huang C.Q., Kim K.I., Liu Z., Moran T., Webb T.R., Whitten J.P., Xie Y.F., McCarthy J.R. Design and synthesis of a series of non-peptide high-affinity human corticotropin-releasing factor 1 receptor antagonists. J. Med. Chem. 1996, 39:4358-4360.
5. Cordeaux Y., Hill S.J. Mechanisms of cross-talk between G-protein-coupled receptors. Neurosignals 2002, 11:45-57.
6. Daaka Y., Luttrell L.M., Lefkowitz R.J. Switching of the coupling of the beta 2-adrenergic receptor to different G proteins by protein kinase A. Nature 1997, 390:88-91.
7. Dai R., Ali M.K., Lezcano N., Bergson C. A crucial role for cAMP and protein kinase A in D1 dopamine receptor regulated intracellular calcium transients. Neurosignals 2008, 16:112-123.
8. Dautzenberg F.M., Hauger R.L. G-protein-coupled receptor kinase 3- and protein kinase C-mediated desensitization of the PACAP receptor type 1 in human Y-79 retinoblastoma cells. Neuropharmacology 2001, 40:394-407.
9. Dautzenberg F.M., Hauger R.L. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol. Sci. 2002, 23:71-77.
10. Dautzenberg F.M., Mevenkamp G., Wille S., Hauger R.L. N-terminal splice variants of the type I PACAP receptor: isolation, characterization and ligand binding/selectivity determinants. J. Neuroendocrinol. 1999, 11:941-949.
11. 1 receptors: a potential mechanism regulating stress adaptation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 280:R935-R946.
12. Dautzenberg F.M., Py-Lang G., Higelin J., Fischer C., Wright M.B., Huber G. Different binding modes of amphibian and human corticotropin-releasing factor type 1 and type 2 receptors: evidence for evolutionary differences. J. Pharmacol. Exp. Ther. 2001, 296:113-120.
13. 2(a)) receptors: phospholipase C-mediated responses in human embryonic kidney 293 but not SK-N-MC neuroblastoma cells. Biochem. Pharmacol. 2004, 68:1833-1844.
14. Foster T.C. Calcium homeostasis and modulation of synaptic plasticity in the aged brain. Aging Cell 2007, 6:319-325.
15. 2(a) receptors endogenously expressed in human retinoblastoma Y79 cells: passage-dependent regulation of functional receptors. J. Neurochem. 2008, 104:926-936.
16. Gutknecht E., Van der Linden I., Van Kolen K., Verhoeven K.F., Vauquelin G., Dautzenberg F.M. Molecular mechanisms of corticotropin-releasing factor receptor-induced calcium signaling. Mol. Pharmacol. 2009, 75:648-657.
17. Hauger R.L., Dautzenberg F.M., Flaccus A., Liepold T., Spiess J. Regulation of corticotropin-releasing factor receptor function in human Y-79 retinoblastoma cells: rapid and reversible homologous desensitization but prolonged recovery. J. Neurochem. 1997, 68:2308-2316.
18. Hauger R.L., Olivares-Reyes J.A., Braun S., Catt K.J., Dautzenberg F.M. Mediation of corticotropin releasing factor type 1 receptor phosphorylation and desensitization by protein kinase C: a possible role in stress adaptation. J. Pharmacol. Exp. Ther. 2003, 306:794-803.
19. Hsu S.Y., Hsueh A.J. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat. Med. 2001, 7:605-611.
20. Kelly E., Bailey C.P., Henderson G. Agonist-selective mechanisms of GPCR desensitization. Br. J. Pharmacol. 2008, 153(Suppl 1):S379-S388.
21. 2 receptor. Proc. Natl Acad. Sci. USA 2001, 98:7570-7575.
22. Lezcano N., Bergson C. D1/D5 dopamine receptors stimulate intracellular calcium release in primary cultures of neocortical and hippocampal neurons. J. Neurophysiol. 2002, 87:2167-2175.
23. Markovic D., Papadopoulou N., Teli T., Randeva H., Levine M.A., Hillhouse E.W., Grammatopoulos D.K. Differential responses of corticotropin-releasing hormone receptor type 1 variants to protein kinase C phosphorylation. J. Pharmacol. Exp. Ther. 2006, 319:1032-1042.
24. Mattson M.P. Calcium and neurodegeneration. Aging Cell 2007, 6:337-350.
25. Meszaros J.G., Gonzalez A.M., Endo-Mochizuki Y., Villegas S., Villarreal F., Brunton L.L. Identification of G protein-coupled signaling pathways in cardiac fibroblasts: cross talk between G(q) and G(s). Am. J. Physiol. Cell Physiol. 2000, 278:C154-C162.
26. Olianas M.C., Ennas M.G., Lampis G., Onali P. Presence of pituitary adenylate cyclase-activating polypeptide receptors in Y-79 human retinoblastoma cells. J. Neurochem. 1996, 67:1293-1300.
27. Perrin M.H., Vale W.W. Corticotropin releasing factor receptors and their ligand family. Ann. NY Acad. Sci. 1999, 885:312-328.
28. Reyes T.M., Lewis K., Perrin M.H., Kunitake K.S., Vaughan J., Arias C.A., Hogenesch J.B., Gulyas J., Rivier J., Vale W.W., Sawchenko P.E. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc. Natl Acad. Sci. USA 2001, 98:2843-2848.
29. Ruhmann A., Bonk I., Lin C.R., Rosenfeld M.G., Spiess J. Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30. Proc. Natl Acad. Sci. USA 1998, 95:15264-15269.
30. Selbie L.A., Hill S.J. G protein-coupled-receptor cross-talk: the fine-tuning of multiple receptor-signalling pathways. Trends Pharmacol. Sci. 1998, 19:87-93.
31. 2+ stores available to receptors linked to inositol trisphosphate formation. J. Biol. Chem. 2000, 275:1807-1813.
32. 2+ from different intracellular pools. Biochem. J. 2000, 351(Pt 3):683-686.
33. Steckler T., Dautzenberg F.M. Corticotropin-releasing factor receptor antagonists in affective disorders and drug dependence-an update. CNS Neurol. Disord. Drug Targets 2006, 5:147-165.
34. 2+ store that is responsive to stop-flow medium changes and insensitive to caffeine and ryanodine. Biochem. J. 1999, 343(Pt 1):39-44.
35. 3 receptors by cAMP. J. Cell Biol. 2008, 183:297-311.
36. Vauquelin G., Von Mentzer B. G Protein-Coupled Receptors: Molecular Pharmacology 2007, 56-64. John Wiley & Sons Ltd. (Ed.).
37. Verkhratsky A. Physiology and pathophysiology of the calcium store in the endoplasmic reticulum of neurons. Physiol. Rev. 2005, 85:201-279.
38. 2+. Biochem. J. 2003, 374:281-296.
39. West A.E., Chen W.G., Dalva M.B., Dolmetsch R.E., Kornhauser J.M., Shaywitz A.J., Takasu M.A., Tao X., Greenberg M.E. Calcium regulation of neuronal gene expression. Proc. Natl Acad. Sci. USA 2001, 98:11024-11031.
40. 2+ entry. J. Biol. Chem. 1998, 273:133-142.